Literature DB >> 7322489

Giant cell (reparative) granuloma of the orbit.

P C Hoopes, R L Anderson, F C Blodi.   

Abstract

Clinically and histologically, there exists considerable controversy as to what constitutes a giant cell tumor. There is an increasing awareness that the term giant cell tumors should not be used indiscriminately in describing lesions of the mandible, maxilla, and facial bones which contain multinucleated giant cells. This paper reports a rare case of giant cell reparative granuloma of the orbit. The differentiation between giant cell reparative granuloma and the true giant cell tumor is discussed and a description of the visual symptomatology associated with these lesions of th sphenoid bone is presented. These tumors must be removed completely to prevent recurrence.

Entities:  

Mesh:

Year:  1981        PMID: 7322489     DOI: 10.1016/s0161-6420(81)34851-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Intracranial giant cell reparative granuloma arising from the temporal lobe area: MR findings.

Authors:  T L Mohammed; D P Brummett; F J Hahn; P Sharma
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

2.  Giant cell reparative granuloma of the nasal cavity.

Authors:  Jonathan M Morris; John I Lane; Robert J Witte; Dana M Thompson
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

3.  Giant cell reparative granuloma of the petrous temporal bone: a case report and literature review.

Authors:  J C Williams; W E Thorell; J S Treves; M E Fidler; G F Moore; L G Leibrock
Journal:  Skull Base Surg       Date:  2000

4.  Recurrent giant cell reparative granuloma of the skull base and the paranasal sinuses presenting with acute one-sided blindness.

Authors:  Stefan K-R Plontke; Claus-Peter Adler; Jan Gawlowski; Ulrike Ernemann; Sigrid A Friese; Peter K Plinkert
Journal:  Skull Base       Date:  2002-02

5.  Eosinophilic granuloma of the orbit: a paradox of aggressive destruction responsive to minimal intervention.

Authors:  Gerald J Harris; Kyung In Woo
Journal:  Trans Am Ophthalmol Soc       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.